(Q40181578)

18 September 2017

1 reference

title

The pharmacokinetics of antibiotics used to treat peritoneal dialysis-associated peritonitis (English)

1 reference

18 September 2017

0 references

1 reference

Johnson CA

1

1 reference

18 September 2017

Zimmerman SW

series ordinal

2

1 reference

18 September 2017

Rogge M

series ordinal

3

1 reference

18 September 2017

publication date

1 July 1984

1 reference

American Journal of Kidney Diseases

18 September 2017

published in

1 reference

18 September 2017

volume

4

1 reference

18 September 2017

issue

1

1 reference

18 September 2017

page(s)

3-17

1 reference

Peritonitis in continuous ambulatory peritoneal dialysis

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Peritoneal Abnormalities during Infectious Episodes of Continuous Ambulatory Peritoneal Dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Pharmacology of Cefazolin in Patients with Normal and Abnormal Renal Function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Effects of renal failure and dialysis on cefazolin pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Pharmacology of intraperitoneal cefazolin in patients undergoing peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Cefazolin and cephalexin kinetics in continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Pharmacokinetics of cefamandole in patients undergoing hemodialysis and peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Pharmacokinetics of cefamandole in patients with renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Cefoxitin disposition during peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Laboratory diagnosis and oral treatment of CAPD peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Peritonitis in continuous ambulatory peritoneal dialysis. Laboratory and clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Ceftizoxime elimination kinetics in continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Moxalactam kinetics during chronic ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Intraperitoneal and intravenous cefoperazone kinetics during continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Cefuroxime: human pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

The new beta-lactamase-stable cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

In Vitro Activity and β-Lactamase Stability of Cefazaflur Compared with Those of β-Lactamase-Stable Cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

In vitro studies with cefazolin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Cefuroxime, a Beta-Lactamase-Resistant Cephalosporin with a Broad Spectrum of Gram-Positive and -Negative Activity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Comparison of In Vitro Activity of Cephalexin, Cephradine, and Cefaclor

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Vancomycin pharmacokinetics in patients with peritonitis on peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Peritoneal Transport of Vancomycin during Peritoneal Dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Peritoneal transport of vancomycin in 4 patients undergoing continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Vancomycin kinetics during continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Efficacy of intravenous vancomycin in the treatment of gram-positive peritonitis in long-term peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

1 reference

7 January 2021

Comparison of the in vitro activities of teichomycin A2 and vancomycin against staphylococci and enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

The Use of Gentamicin in Peritoneal Dialysis: I. Pharmacologic Results

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Pharmacokinetics of gentamicin during peritoneal dialysis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Evaluation of gentamicin pharmacokinetics during peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Unidirectional absorption of gentamicin from the peritoneum during continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Pharmacokinetics of gentamicin in patients undergoing continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Tobramycin concentrations during peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Effect of Peritoneal Dialysis on Serum Levels of Tobramycin and Clindamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Tobramycin and gentamicin concentrations in the serum of normal and anephric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Tobramycin kinetics during continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Effect of renal failure and dialysis on the serum concentration of the aminoglycoside amikacin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Pharmacokinetics of amikacin during hemodialysis and peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Management of Amikacin Overdose

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Comparative penetration of amikacin, gentamicin, and penicillin g into exudate fluid in experimental sterile peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Peritoneal transfer of kanamycin and its use in peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Comparative activity of netilmicin, gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

In vitro activity of netilmicin compared with gentamicin, tobramycin, amikacin, and kanamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Administration of ticarcillin, a new antipseudomonal antibiotic, in patients undergoing dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Carbenicillin administration in patients with severe renal failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Effects of impaired renal function, hemodialysis, and peritoneal dialysis on the pharmacokinetics of mezlocillin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Microbiology, Pharmacology, and Clinical Use of Mezlocillin Sodium

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Comparative activity in vitro of ticarcillin, BL-P1654, and carbenicillin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

In vitro activity of mezlocillin and azlocillin compared with that of four other penicillins and two aminoglycosides.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Animal model distinguishing in vitro from in vivo carbenicillin-aminoglycoside interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Pharmacokinetics of sulfamethoxazole--trimethoprim combination during chronic peritoneal dialysis: effect of peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Treatment of peritonitis in continuous ambulatory peritoneal dialysis patients with co-trimoxazole.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Stability of antimicrobial agents in peritoneal dialysate

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Stability of single and combination antimicrobial agents in various peritoneal dialysates in the presence of insulin and heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Effect of peritoneal dialysis solution on the antimicrobial activity of cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

Antibiotic Activity in Peritoneal Dialysate

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2884%2980020-7

7 January 2021

10.1016/S0272-6386(84)80020-7

Identifiers

DOI

1 reference

18 September 2017

1 reference